Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probucol: pharmacology and clinical application.

P Zimetbaum1, H Eder, W Frishman

  • 1Department of Medicine, Albert Einstein College of Medicine, Bronx, New York.

Journal of Clinical Pharmacology
|January 1, 1990
PubMed
Summary

Probucol lowers harmful cholesterol levels and offers antioxidant benefits, potentially aiding in preventing atherosclerotic vascular disease. Further research is needed to confirm its life-prolonging effects in humans.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shielding effectiveness of X-ray protective garment.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2021
Same author

TERTIARY X-RADIATION-A PROBLEM FOR STAFF PROTECTION?

Radiation protection dosimetry·2020
Same author

Spontaneous dislocation of second cervical vertebra due to metastasis from mammary carcinoma.

Neurology India·2018
Same author

Assessment of clinical occupational dose reduction effect of a new interventional cardiology shield for radial access combined with a scatter reducing drape.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2015
Same author

A New Design of a Lead-Acrylic Shield for Staff Dose Reduction in Radial and Femoral Access Coronary Catheterization.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2015
Same author

QTc prolongation and treatment of multidrug-resistant tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2015

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Elevated cholesterol, LDL-cholesterol, and VLDL-cholesterol are established risk factors for atherosclerotic vascular disease.
  • Oxidative modification of LDL contributes to lipid deposition in blood vessel walls.

Purpose of the Study:

  • To evaluate the effects of Probucol on lipid profiles and its potential role in managing atherosclerotic vascular disease.
  • To assess the antioxidant properties of Probucol and their impact on LDL modification.

Main Methods:

  • The study investigated the effects of orally administered Probucol.
  • Lipid levels (total cholesterol, LDL-cholesterol, HDL-cholesterol) were monitored.
  • Antioxidant activity and potential modification of lipoprotein metabolism were assessed.

Related Experiment Videos

Main Results:

  • Probucol effectively reduced total cholesterol and LDL-cholesterol levels.
  • The drug also decreased HDL-cholesterol levels.
  • Probucol demonstrated antioxidant activity, potentially inhibiting LDL oxidative modification and enhancing cholesterol removal from peripheral tissues.

Conclusions:

  • Probucol is a well-tolerated agent that reduces key lipid risk factors for atherosclerotic vascular disease.
  • Its antioxidant properties may offer additional cardiovascular benefits.
  • The long-term impact of Probucol on human survival requires further investigation.